490 related articles for article (PubMed ID: 20494258)
21. [Diagnostic testing in fragile X syndrome].
Sireteanu A; Rusu C
Rev Med Chir Soc Med Nat Iasi; 2006; 110(4):968-71. PubMed ID: 17438909
[TBL] [Abstract][Full Text] [Related]
22. Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies.
Ryynänen M; Heinonen S; Makkonen M; Kajanoja E; Mannermaa A; Pertti K
Eur J Hum Genet; 1999; 7(2):212-6. PubMed ID: 10196705
[TBL] [Abstract][Full Text] [Related]
23. Penetrance of marked cognitive impairment in older male carriers of the FMR1 gene premutation.
Sévin M; Kutalik Z; Bergman S; Vercelletto M; Renou P; Lamy E; Vingerhoets FJ; Di Virgilio G; Boisseau P; Bezieau S; Pasquier L; Rival JM; Beckmann JS; Damier P; Jacquemont S
J Med Genet; 2009 Dec; 46(12):818-24. PubMed ID: 19542082
[TBL] [Abstract][Full Text] [Related]
24. [Neurological signs in the adult with fragile-X premutation].
Cabanyes-Truffino J
Neurologia; 2010 May; 25(4):222-7. PubMed ID: 20609299
[TBL] [Abstract][Full Text] [Related]
25. The risk of fragile X premutation expansion is lower in carriers detected by general prenatal screening than in carriers from known fragile X families.
Geva E; Yaron Y; Shomrat R; Ben-Yehuda A; Zabari S; Peretz H; Naiman T; Yeger H; Orr-Urtreger A
Genet Test; 2000; 4(3):289-92. PubMed ID: 11142761
[TBL] [Abstract][Full Text] [Related]
26. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study.
Rohr J; Allen EG; Charen K; Giles J; He W; Dominguez C; Sherman SL
Hum Reprod; 2008 May; 23(5):1220-5. PubMed ID: 18310677
[TBL] [Abstract][Full Text] [Related]
27. Preconceptional and prenatal screening for fragile X syndrome: experience with 40,000 tests.
Berkenstadt M; Ries-Levavi L; Cuckle H; Peleg L; Barkai G
Prenat Diagn; 2007 Nov; 27(11):991-4. PubMed ID: 17705235
[TBL] [Abstract][Full Text] [Related]
28. [Diagnosis of fragile X syndrome].
Glover G; Bernabé MJ; Carbonell P
Rev Neurol; 2001 Oct; 33 Suppl 1():S6-9. PubMed ID: 12447811
[TBL] [Abstract][Full Text] [Related]
29. [New methods for the diagnosis of fragile X syndrome: a study of the FMRP in blood and hair].
Ramos-Fuentes FJ
Rev Neurol; 2001 Oct; 33 Suppl 1():S9-S13. PubMed ID: 12447812
[TBL] [Abstract][Full Text] [Related]
30. Advances in research on the fragile X syndrome.
Mazzocco MM
Ment Retard Dev Disabil Res Rev; 2000; 6(2):96-106. PubMed ID: 10899802
[TBL] [Abstract][Full Text] [Related]
31. [Screening for fragile X syndrome. International experiences].
Vuust J; Larsen LA; Grønskov K; Nørgaard-Pedersen B; Brøndum-Nielsen K
Ugeskr Laeger; 2006 Oct; 168(43):3704-9. PubMed ID: 17069733
[TBL] [Abstract][Full Text] [Related]
32. Premature ovarian failure: a phenotypic expression of fragile X premutation.
Holoch K; Stein Q; Flanagan J; Hansen K
S D Med; 2008 Jan; 61(1):13, 15. PubMed ID: 18323308
[TBL] [Abstract][Full Text] [Related]
33. Fragile X syndrome prenatal diagnosis: parental attitudes and reproductive responses.
Xunclà M; Badenas C; Domínguez M; Rodríguez-Revenga L; Madrigal I; Jiménez L; Soler A; Borrell A; Sánchez A; Milà M
Reprod Biomed Online; 2010 Oct; 21(4):560-5. PubMed ID: 20801083
[TBL] [Abstract][Full Text] [Related]
34. [Neurodevelopmental (fragile X syndrome) and neurodegenerative (tremor/ataxia syndrome) disorders associated to the 'growth' of a gene].
Castro-Volio I; Cuenca-Berger P
Rev Neurol; 2005 Apr 1-15; 40(7):431-7. PubMed ID: 15849678
[TBL] [Abstract][Full Text] [Related]
35. Motor and mental dysfunction in mother-daughter transmitted FXTAS.
Rodriguez-Revenga L; Pagonabarraga J; Gómez-Anson B; López-Mourelo O; Madrigal I; Xunclà M; Kulisevsky J; Milà M
Neurology; 2010 Oct; 75(15):1370-6. PubMed ID: 20938029
[TBL] [Abstract][Full Text] [Related]
36. [Family impact of FXTAS diagnosis: genetic counseling for at-risk relatives].
Lesca G; Lejeune S; Hernette D; Héron D
Rev Neurol (Paris); 2013; 169(6-7):515-8. PubMed ID: 23557641
[TBL] [Abstract][Full Text] [Related]
37. Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel.
Toledano-Alhadef H; Basel-Vanagaite L; Magal N; Davidov B; Ehrlich S; Drasinover V; Taub E; Halpern GJ; Ginott N; Shohat M
Am J Hum Genet; 2001 Aug; 69(2):351-60. PubMed ID: 11443541
[TBL] [Abstract][Full Text] [Related]
38. Fragile X-premutation tremor/ataxia syndrome (FXTAS) in a young woman: clinical, genetics, MRI and 1H-MR spectroscopy correlates.
Sarac H; Henigsberg N; Markeljević J; Pavlisa G; Hof PR; Simić G
Coll Antropol; 2011 Jan; 35 Suppl 1():327-32. PubMed ID: 21648356
[TBL] [Abstract][Full Text] [Related]
39. [Triplet expansion cytosine-guanine-guanine: Three cases of OMIM syndrome in the same family].
González-Pérez J; Izquierdo-Álvarez S; Fuertes-Rodrigo C; Monge-Galindo L; Peña-Segura JL; López-Pisón FJ
Med Clin (Barc); 2016 Apr; 146(7):311-5. PubMed ID: 26776484
[TBL] [Abstract][Full Text] [Related]
40. Identification of fragile X pre-mutation carriers in the Chinese obstetric population using a robust FMR1 polymerase chain reaction assay: implications for screening and prenatal diagnosis.
Cheng YK; Lin CS; Kwok YK; Chan YM; Lau TK; Leung TY; Choy KW
Hong Kong Med J; 2017 Apr; 23(2):110-6. PubMed ID: 28253484
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
